As new standards of cancer care are being implemented nationwide and our health care system is changing, Triage Cancer hopes to be in the forefront of educating health care providers, and the cancer community in general, so that they can best utilize the valuable tools and resources that are available for their constituencies.
Triage Cancer collaborates with experts in the areas of medicine, mental health, nursing, social work, patient navigation, nutrition, oncofertility, law, employment, education, financial management, insurance, relationships, sexuality and intimacy, pain and palliative care, advocacy, and other areas of cancer survivorship.
The Triage Cancer Scientific Advisory Council provides guidance on substantive areas of cancer survivorship so that we may best serve the cancer community.
Fumiko Chino, MD is a cancer researcher, Assistant Attending in Radiation Oncology, and co-Lead of the Affordability Working Group at Memorial Sloan Kettering Cancer Center. She is also one of the Directors at the Costs of Care group, a NGO working to improve affordability in healthcare.
Her research is focused on patient-centered care including the financial toxicity of cancer care and survivorship, healthcare disparities, equity, and access. She is the recipient of the inaugural 2022 ASCO Excellence in Equity Award. Her work has been published in Lancet Oncology, JAMA Internal Medicine, and JAMA Oncology, and her commentary on healthcare reform and cancer care has been featured in the New England Journal of Medicine, JAMA Oncology, and The Los Angeles Times. Her work has been covered by national news media outlets including the New York Times, Forbes, NPR, and NBC News. She has received research support from the NIH, the Radiation Oncology Institute, and the Chanel Foundation and has spoken across the US and internationally on equity and the costs of care. Her clinical focus is on the treatment of breast and gynecological cancers.